Back to results
US 2019/0293647 A1Published application
Circulating astrocytes and mfsd2a as biomarkers
AssigneesSheng-He Huang, Alec Chan
InventorSheng-He Huang
Life of this patent
Estimating the term…
Abstract
The invention provides the use of circulating astrocytes (cAstr) and the Major Facilitator Superfamily Domain containing Protein 2a (Mfsd2a) as biomarkers, and their combined use with other related circulating markers (cBMEC and EPC) in early detection and diagnosis of cerebrovascular diseases (CVD) or central nervous system (CNS) disorders.
Claims8
1-19. (canceled)
A method for diagnosing a traumatic brain injury, the method comprising:
- (a) obtaining a peripheral blood sample from a human subject;
- (b) using a first magnetic bead to concentrate circulating brain microvascular endothelial cells from the peripheral blood sample;
- (c) using a second magnetic bead to isolate circulating brain microvascular endothelial cells containing major facilitator superfamily domain-containing protein 2,
- (d) staining the isolated circulating brain microvascular endothelial cells with a conjugated antibody;
- (e) counting the number of the stained brain microvascular endothelial cells;
- and
- (f) determining that the human subject has traumatic brain injury when a density of the circulating brain microvascular endothelial cells is greater than 90 count per milliliter.
4 more elements
A method for diagnosing a brain microbial infection, the method comprising:
- (a) obtaining a peripheral blood sample from a human subject;
- (b) using a first magnetic bead to concentrate circulating brain microvascular endothelial cells from the peripheral blood sample;
- (c) using a second magnetic bead to isolate circulating brain microvascular endothelial cells containing major facilitator superfamily domain-containing protein 2,
- (d) staining the isolated circulating brain microvascular endothelial cells with a conjugated antibody;
- (e) counting the number of the stained brain microvascular endothelial cells;
- and
- (f) determining that the human subject has brain microbial infection when a density of the circulating brain microvascular endothelial cells is greater than 90 count per milliliter.
4 more elements
A method for diagnosing blood brain barrier injury, the method comprising:
- (a) obtaining a peripheral blood sample from a human subject;
- (b) using a first magnetic bead to concentrate circulating brain microvascular endothelial cells from the peripheral blood sample;
- (c) using a second magnetic bead to isolate circulating brain microvascular endothelial cells containing major facilitator superfamily domain-containing protein 2,
- (d) staining the isolated circulating brain microvascular endothelial cells with a conjugated antibody;
- (e) counting the number of the stained brain microvascular endothelial cells;
- and
- (f) determining that the human subject suffers an injury to his blood brain barrier when a density of the circulating brain microvascular endothelial cells is greater than 90 count per milliliter.
4 more elements
Dependencies are inferred from the claim text.